A population-based validation of the prognostic model PREDICT for early breast cancer

European Journal of Surgical Oncology

Volumn 37, Issue 5, 2011, Pages 411-417

  Wishart, G C ^a   Bajdik, C D ^e   Azzato, E M ^b,c   Dicks, E ^b   Greenberg, D C ^d   Rashbass, J ^d   Caldas, C ^a,b,f   Pharoah, P D P ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Eastern Cancer Registration and Information Centre   (United Kingdom)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Breast; Model validation; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT!; ADULT; ARTICLE; BREAST CANCER; CALIBRATION; CANADA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MODEL; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREDICT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; VALIDATION PROCESS;

ADULT; AGED; BREAST NEOPLASMS; BRITISH COLUMBIA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GREAT BRITAIN; HUMANS; INTERNET; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; ROC CURVE; SURVIVAL RATE;

EID: 79954426278     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.02.001     Document Type: Article

References (15)

1. J.L. Haybittle, R.W. Blamey, and C.W. Elston A prognostic index in primary breast cancer Br J Cancer 45 1982 361 366 (Pubitemid 12122304)
2. J.H. Todd, C. Dowle, and M.R. Williams Confirmation of a prognostic index in primary breast cancer Br J Cancer 56 1987 489 492 (Pubitemid 17146357)
3. G. D'Eredita, C. Giardina, and M. Martellotta Prognostic factors in breast cancer: the predictive value of the Nottingham prognostic index in patients with a long-term follow-up that were treated in a single institution Eur J Cancer 37 2001 591 596 (Pubitemid 32261016)
4. R.W. Blamey, I.O. Ellis, and S.E. Pinder Survival of invasive breast cancer according to the Nottingham prognostic index in cases diagnosed in 1990-1999 Eur J Cancer 43 2007 1548 1555 (Pubitemid 46901016)
5. P.M. Ravdin, L.A. Siminoff, and G.J. Davis Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 2001 980 991 (Pubitemid 32176272)
6. Early Breast Cancer Trialists Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1998 1451 1467
7. Early Breast Cancer Trialists Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 1998 930 942
8. I.A. Olivotto, C.D. Bajdik, and P.M. Ravdin Population-based validation of the prognostic model ADJUVANT! for early breast cancer J Clin Oncol 23 2005 2716 2725 (Pubitemid 46179461)
9. H.E. Campbell, M.A. Taylor, and A.L. Harris An investigation into the performance of the Adjuvant! online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom Br J Cancer 101 2009 1074 1084
10. G.C. Wishart, E.M. Azzato, and D.C. Greenberg PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer Breast Cancer Res 12 2010 R1
11. E.M. Azzato, D. Greenberg, and M. Shah Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? Br J Cancer 100 2009 1806 1811
12. H. Joensuu, T. Lehtimaki, and K. Holli Risk for distant recurrence of breast cancer detected by mammography screening or other methods J Am Med Assoc 292 2004 1064 1073 (Pubitemid 39129196)
13. Y. Shen, Y. Yang, and L.Y. Inoue Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 2005 1195 1203 (Pubitemid 41258225)
14. S.J. Dawson, S.W. Duffy, and F.M. Blows Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival Br J Cancer 101 2009 1338 1344
15. G.C. Wishart, D.C. Greenberg, and P.D. Britton Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer 98 2008 1741 1744 (Pubitemid 351748836)